Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies

J Hart1, P Putsathit, D R Knight

  • 1Microbiology, PathWest Laboratory Medicine, Princess Margaret Hospital, Perth, Western Australia, Australia, julie.hart@health.wa.gov.au.

Insights

Accurate diagnosis of Clostridium difficile infection (CDI) is vital in children. Molecular tests showed the best performance for detecting CDI in a high-prevalence pediatric hospital setting.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pediatric Healthcare

Background:

  • Clostridium difficile infection (CDI) incidence is rising in hospitalized children.
  • Emergence of hypervirulent strains and community-acquired CDI necessitates prompt diagnosis.
  • Accurate and rapid diagnostic methods are crucial for effective treatment and infection control in pediatric populations.

Purpose of the Study:

  • To validate commonly used Clostridium difficile diagnostic tests in a pediatric hospital setting.
  • To compare the performance of various diagnostic methods, including immunoassays, culture, and molecular assays.
  • To determine the optimal diagnostic strategy for CDI in a high-prevalence pediatric population.

Main Methods:

  • Prospective validation of diagnostic tests on 150 stool samples from 75 pediatric patients.
  • Tests included: C. Diff Quik Chek Complete (GDH and toxin), Illumigene, GeneOhm, cycloserine cefoxitin fructose agar (CCFA) culture, and cell culture cytotoxin neutralisation assay (CCNA).
  • Reference standard involved CCFA or Cdiff Chromagar culture, PCR for toxin genes, and PCR ribotyping.

Main Results:

  • High prevalence of CDI (43%) observed in the study population.
  • Glutamate dehydrogenase (GDH) test showed a low negative predictive value (NPV).
  • Cell culture cytotoxin neutralisation assay (CCNA) and Quik Chek Complete toxin assay had poor sensitivity. Molecular methods demonstrated 89% sensitivity, outperforming other tests and algorithms.
  • Ribotype UK014/20 was predominant. GDH NPV and molecular sensitivities were lower than in adult studies.

Conclusions:

  • Commonly used tests like Quik Chek Complete and CCNA are unreliable for detecting toxigenic CDI in children.
  • GDH-based algorithms demonstrated reduced sensitivity in this pediatric cohort.
  • Molecular methods alone are recommended for diagnosing CDI in high-prevalence pediatric populations due to superior performance characteristics.